18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Hepatocellular Carcinoma
Interventions
DIAGNOSTIC_TEST

18F-FDGal PET/CT or PET/MRI

All patients suspected of or diagnosed with HCC will be offered an initial 18F-FDGal PET/CT or PET/MRI scan. Moreover, patients who undergo loco-regional treatment (resection, ablation (radiation or microwave), chemo- or radio-embolization) are re-examined with 18F-FDGal. The scans will be performed 1-2 months and 3-5 months after the loco-regional treatment. The images will be analyzed by an experienced PET specialist and the CT or MR images by an experienced radiologist for focal lesions and compared to other imaging modalities. The investigators expect approximately 25 patients per year during a 5-year period and as such aim at a total of 125 patients

Trial Locations (1)

8200

RECRUITING

Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER